|
Market Closed -
Nasdaq
04:00:00 2026-09-24 pm EDT
|
5-day change | 1st Jan Change | ||
| 236.28 USD | +0.60% |
|
-3.00% | +38.99% |
| Sep. 21 | Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on | RE |
| Sep. 16 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| Market Cap | 15.33B 13.48B 12.7B 11.6B 21.69B 1,471B 21.88B 152B 59B 750B 57.57B 56.31B 2,435B | P/E 2026 * |
16.2x | P/E 2027 * | 14.4x |
|---|---|---|---|---|---|
| Enterprise Value | 17.17B 15.09B 14.22B 12.99B 24.29B 1,647B 24.5B 170B 66.07B 840B 64.47B 63.06B 2,727B | EV / Sales 2026 * |
3.64x | EV / Sales 2027 * | 3.01x |
| Free-Float |
96.82% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| JAZZ | Delayed | |
CBOE
| JAZZ | Real-time | |
|
Boerse Muenchen
| J7Z | Real-time | |
|
Tradegate
| J7Z | Real-time | |
|
Xetra
| J7Z | Delayed | |
|
Deutsche Boerse AG
| J7Z | Delayed | |
|
Börse Stuttgart
| J7Z | Delayed | |
|
Berne S.E.
| J7Z | End-of-day quote | |
|
Borsa Italiana
| 1JAZZ | End-of-day quote |
Last Transcript: Jazz Pharmaceuticals plc
| 1 day | +0.60% | ||
| 1 week | -3.00% | ||
| Current month | -5.74% | ||
| 1 month | -7.08% | ||
| 3 months | +2.62% | ||
| 6 months | +29.60% | ||
| Current year | +38.99% |
| 1 week | 231.59 |  | 244.55 |
| 1 month | 231.59 | | 266.38 |
| Current year | 156.95 | | 266.38 |
| 1 year | 125.78 | | 266.38 |
| 3 years | 95.49 | | 266.38 |
| 5 years | 95.49 | | 266.38 |
| 10 years | 86.88 | | 266.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Renée Galá
CEO | Chief Executive Officer | 54 | 2025-08-10 |
Philip Johnson
DFI | Director of Finance/CFO | 62 | 2024-02-29 |
Mary Henderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 2023-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CHM | Chairman | 62 | 2003-02-28 |
Seamus Mulligan
BRD | Director/Board Member | 65 | 2012-01-17 |
Rick Winningham
BRD | Director/Board Member | 66 | 2009-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/10/26 | Sell | General Counsel | -1,200 | 0.0018% | ||
| 9/8/26 | Tax | Chief Executive Officer | -3,967 | 0.0061% | ||
| 9/8/26 | Tax | Chief Technology Officer | -1,427 | 0.0022% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.60% | -3.00% | +82.60% | +79.34% | 15.25B | |
| +2.68% | +3.87% | +58.22% | +114.68% | 1,026B | |
| +0.56% | +1.27% | +53.29% | +68.65% | 649B | |
| +0.02% | +0.99% | +19.10% | +73.58% | 468B | |
| +0.06% | +0.25% | +37.03% | +45.71% | 352B | |
| +1.16% | +4.10% | +21.99% | +29.39% | 271B | |
| -0.24% | +2.18% | +10.14% | +12.26% | 256B | |
| -0.01% | +7.89% | +41.57% | +51.68% | 220B | |
| -1.11% | +1.36% | +30.85% | +99.56% | 188B | |
| +0.30% | -7.19% | -32.43% | -60.56% | 170B | |
| Average | +0.14% | +0.77% | +32.23% | +51.43% | 361.43B | |
| Weighted average by Cap. | +0.16% | +1.23% | +37.49% | +67.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.72B 4.15B 3.91B 3.57B 6.67B 453B 6.73B 46.81B 18.15B 231B 17.71B 17.32B 749B | 4.99B 4.39B 4.13B 3.78B 7.06B 479B 7.13B 49.56B 19.22B 244B 18.75B 18.34B 793B |
| Net income | 1B 883M 832M 760M 1.42B 96.41B 1.43B 9.97B 3.87B 49.16B 3.77B 3.69B 160B | 1.14B 1B 945M 864M 1.61B 110B 1.63B 11.33B 4.39B 55.85B 4.29B 4.19B 181B |
| Net Debt | 1.84B 1.61B 1.52B 1.39B 2.6B 176B 2.62B 18.23B 7.07B 89.86B 6.9B 6.75B 292B | -277M -244M -230M -210M -392M -26.62B -396M -2.75B -1.07B -13.57B -1.04B -1.02B -44.06B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | $236.21 | +0.57% | 541,495 |
| 26-09-23 | $234.88 | -2.37% | 792,218 |
| 26-09-22 | $240.57 | -0.37% | 482,009 |
| 26-09-21 | $241.46 | +0.30% | 499,163 |
| 26-09-18 | $240.74 | -1.27% | 2,214,759 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- JAZZ Stock
Select your edition
All financial news and data tailored to specific country editions
